Today: 8 February 2026
Subscribe
Browse Category

Financial Forecasts News 20 December 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston shares plunged nearly 26% Friday after management warned of continued discounting and higher international costs despite beating Q2 FY2026 earnings expectations. Net sales rose 1% to $1.618 billion, with an 8% volume gain offset by an 8% drop in price/mix. The company said margin pressure may persist into the second half of the year.
20 December 2025
···
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) shares fell 11.5% to $80.04 on Dec. 20, 2025, after a STAT News report raised doubts about the effectiveness of its lead drug bitopertin and the FDA’s fast-track voucher process. The stock traded between $71.46 and $94.60 on heavy volume after Truist Securities cited the report, fueling concerns about the viability of accelerated approval.
20 December 2025
·
Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly shares closed at $1,071.44 on Dec. 19, near record highs, after reporting positive Phase 3 results for its oral weight-loss drug orforglipron. The company also cut prices on Zepbound and Mounjaro in the U.S. and Canada. Lilly’s market value surpassed $1 trillion this year amid growing demand for obesity and cardiometabolic treatments.
20 December 2025
···
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ended Friday’s session sharply higher after announcing a blockbuster rare-disease acquisition that immediately reframed the company’s growth story. Shares closed at $61.15, up about 17.7% on the day, with trading volume far above typical levels—classic “big-news repricing” behavior. Yahoo Finance The catalyst: BioMarin’s agreement to buy Amicus Therapeutics (NASDAQ: FOLD) for $14.50 per share in cash, valuing the deal at approximately $4.8 billion. BioMarin says the acquisition adds two marketed, growing therapies—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease)—plus U.S. rights to DMX-200 (a Phase 3 kidney-disease asset), while also resolving a key piece
20 December 2025
··
Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco shares closed Friday at $78.42, up 1.91%, after heavy trading pushed the stock near its all-time high set during the dot-com era. Morgan Stanley raised its price target to $91 on Dec. 17, citing AI infrastructure demand. Jackson Square Capital increased its stake in Cisco during the third quarter. The company faces scrutiny over a newly disclosed high-severity cybersecurity issue.
20 December 2025
··
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave shares surged 22.5% to about $83 in heavy trading after Citigroup resumed coverage with a Buy rating and the U.S. Department of Energy named the company as a Genesis Mission partner. Citi lowered its price target to $135 and flagged “High Risk,” citing strong demand but operational challenges. The stock had dropped 65% from its June high after its March IPO.
20 December 2025
···
National Stock Exchange of India (NSE) Today: Derivatives Reforms, IPO Signals, and Nifty 50 Forecasts as 2026 Approaches

National Stock Exchange of India (NSE) Today: Derivatives Reforms, IPO Signals, and Nifty 50 Forecasts as 2026 Approaches

The National Stock Exchange of India introduced a pre-open session for equity derivatives, aiming to set opening prices through a call auction. On December 20, the Nifty 50 closed at 25,966.40, up 0.58%. The exchange’s listed market capitalization stood at about $5.2 trillion. The long-delayed NSE IPO remains under discussion amid regulatory changes.
20 December 2025
·
Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals shares surged 11% on Dec. 17 after JPMorgan upgraded the stock, then retreated to close at $4.26 on Dec. 19 as trading volume spiked. The moves followed positive Phase 1b/2 data for REC-4881 in familial adenomatous polyposis, showing a median 43% reduction in polyp burden at 13 weeks. Most adverse events were mild or moderate.
20 December 2025
···
Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media & Technology Group Corp. (NASDAQ: DJT) is ending the week the way it often lives: loudly, unpredictably, and with traders glued to their screens. After announcing a surprise plan to merge with nuclear fusion developer TAE Technologies in a deal valued at more than $6 billion, DJT shares ripped higher on massive volume—turning a social-media stock into (at least on paper) a new way to bet on the race to power the AI era. GlobeNewswire+2StockAnalysis+2 As of the latest close Friday, Dec. 19, 2025, DJT finished at about $16.09, following a two-day surge that featured a roughly +42%
20 December 2025
···
Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial will join the Nasdaq-100 on December 22, becoming the first IBEX 35-listed company in the index. The move follows the launch of an €800 million share buyback and a €0.077 per share cash dividend, both set for December. U.S. shares closed at $66.39 on December 19, with trading volume spiking to 61.8 million that day.
20 December 2025
··
NVIDIA Corporation Stock (NVDA) News Today: China H200 Export Review, Intel Investment Cleared, and Fresh 2026 Price Targets

NVIDIA Corporation Stock (NVDA) News Today: China H200 Export Review, Intel Investment Cleared, and Fresh 2026 Price Targets

Nvidia shares rose nearly 4% to $180.99 after news that a U.S. interagency review could allow H200 AI chip sales to China under a licensing framework. The Commerce Department has sent license applications to State, Energy, and Defense for review, with a final decision possible from President Trump if agencies disagree. China remains a key market, but regulatory and geopolitical hurdles persist.
20 December 2025
·
HYMC Stock News and Forecast: Hycroft Mining’s Silver Drill Results, Insider Buying, and 2026 Catalysts as of Dec. 20, 2025

HYMC Stock News and Forecast: Hycroft Mining’s Silver Drill Results, Insider Buying, and 2026 Catalysts as of Dec. 20, 2025

Hycroft Mining shares traded around $16.42 on Dec. 20 after a volatile session, with volume near 4.8 million shares. The stock surged following a Dec. 15 update reporting the highest silver grades yet at its Nevada Vortex target, including a 30.8-meter intercept at 438.58 g/t silver. Drilling continues at both Vortex and Brimstone.
20 December 2025
···
Firefly Aerospace Stock (NASDAQ: FLY) News, Forecasts, and Analysis for Dec. 20, 2025

Firefly Aerospace Stock (NASDAQ: FLY) News, Forecasts, and Analysis for Dec. 20, 2025

Firefly Aerospace shares surged 22.82% Friday to $24.65, with after-hours trading near $25.44. The move followed new analyst coverage from KeyBanc and the appointment of Ramon Sanchez as COO, focused on scaling production. The stock has traded between $16 and $73.80 over the past year. Investors remain focused on execution risks and upcoming lunar-mission partnerships.
20 December 2025
···
Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston shares fell about 20% on December 19 after the company reported fiscal Q2 2026 results that beat expectations but maintained a cautious full-year outlook. The stock closed near $43.94 on December 20. Despite 8% volume growth, price/mix dropped 8%, pressuring margins. Investors focused on the company’s reliance on discounting and muted demand signals.
20 December 2025
···
Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group shares surged 14.6% to $89.46 Friday, Dec. 19, on heavy trading after launching its AI Cloud 3.1 platform with NVIDIA Blackwell Ultra compute. The Amsterdam-based company, formerly Yandex, has become a key AI infrastructure stock, competing with Amazon and Google. Investors remain focused on Nebius’s rapid expansion and spending to meet AI demand.
20 December 2025
··
Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab shares closed at a record $70.52 Friday, up 17.7%, after announcing its largest contract to date: an $805 million U.S. Space Force award to build 18 missile-tracking satellites. The deal is part of a $3.5 billion Space Development Agency program with launches targeted by 2029.
20 December 2025
····
Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Fitch reaffirmed Imperial Brands’ ‘BBB’ rating with a Stable outlook, citing strong cash flow from tobacco and disciplined capital allocation. The company continued its £1.45 billion share buyback, purchasing over 388,000 shares on Dec. 18–19 at around 3,182p each. Fitch expects cigarettes to remain over 90% of revenue by 2028, with NGP at 4.4% in FY25. A $400 million litigation payment is projected for 2026.
20 December 2025
·
GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK agreed to a U.S. drug-pricing deal covering its respiratory portfolio, securing a three-year exemption from tariffs and pledging lower Medicaid prices and direct-to-consumer discounts. The company also received fresh FDA approval for a severe asthma drug and expanded vaccine indications in Europe. GSK’s ADR closed Friday, Dec. 19, at $48.61.
20 December 2025
···
1 … 9 10 11 12 13 … 41

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop